Indies Pharma Jamaica Limited (JMSE: INDIES)

Indies Pharma Jamaica Statistics

Total Valuation

Indies Pharma Jamaica has a market cap or net worth of JMD 3.92 billion. The enterprise value is 4.60 billion.

Market Cap	3.92B
Enterprise Value	4.60B

Important Dates

The next estimated earnings date is Friday, December 13, 2024.

Earnings Date	Dec 13, 2024
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Indies Pharma Jamaica has 1.33 billion shares outstanding. The number of shares has increased by 1.57% in one year.

Current Share Class	n/a
Shares Outstanding	1.33B
Shares Change (YoY)	+1.57%
Shares Change (QoQ)	+18.38%
Owned by Insiders (%)	5.77%
Owned by Institutions (%)	9.04%
Float	247.71M

Valuation Ratios

The trailing PE ratio is 18.37.

PE Ratio	18.37
Forward PE	n/a
PS Ratio	3.49
PB Ratio	3.14
P/TBV Ratio	n/a
P/FCF Ratio	21.22
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.35, with an EV/FCF ratio of 24.90.

EV / Earnings	21.33
EV / Sales	4.05
EV / EBITDA	14.35
EV / EBIT	15.81
EV / FCF	24.90

Financial Position

The company has a current ratio of 8.40, with a Debt / Equity ratio of 0.69.

Current Ratio	8.40
Quick Ratio	4.55
Debt / Equity	0.69
Debt / EBITDA	2.70
Debt / FCF	4.69
Interest Coverage	4.87

Financial Efficiency

Return on equity (ROE) is 17.74% and return on invested capital (ROIC) is 8.65%.

Return on Equity (ROE)	17.74%
Return on Assets (ROA)	8.28%
Return on Capital (ROIC)	8.65%
Revenue Per Employee	16.00M
Profits Per Employee	3.04M
Employee Count	71
Asset Turnover	0.52
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.77%
50-Day Moving Average	3.05
200-Day Moving Average	2.75
Relative Strength Index (RSI)	51.80
Average Volume (20 Days)	429,776

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indies Pharma Jamaica had revenue of JMD 1.14 billion and earned 215.57 million in profits. Earnings per share was 0.16.

Revenue	1.14B
Gross Profit	671.40M
Operating Income	290.84M
Pretax Income	245.10M
Net Income	215.57M
EBITDA	279.11M
EBIT	290.84M
Earnings Per Share (EPS)	0.16

Balance Sheet

The company has 185.77 million in cash and 865.19 million in debt, giving a net cash position of -679.41 million or -0.51 per share.

Cash & Cash Equivalents	185.77M
Total Debt	865.19M
Net Cash	-679.41M
Net Cash Per Share	-0.51
Equity (Book Value)	1.25B
Book Value Per Share	0.94
Working Capital	666.79M

Cash Flow

In the last 12 months, operating cash flow was 188.00 million and capital expenditures -3.40 million, giving a free cash flow of 184.61 million.

Operating Cash Flow	188.00M
Capital Expenditures	-3.40M
Free Cash Flow	184.61M
FCF Per Share	0.14

Margins

Gross margin is 59.11%, with operating and profit margins of 25.61% and 18.98%.

Gross Margin	59.11%
Operating Margin	25.61%
Pretax Margin	21.58%
Profit Margin	18.98%
EBITDA Margin	24.57%
EBIT Margin	25.61%
FCF Margin	16.25%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 3.61%.

Dividend Per Share	0.11
Dividend Yield	3.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	68.18%
Buyback Yield	-1.57%
Shareholder Yield	2.04%
Earnings Yield	5.44%
FCF Yield	4.71%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Indies Pharma Jamaica has an Altman Z-Score of 3.92.

Altman Z-Score	3.92
Piotroski F-Score	n/a